|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
09-30-2010, 02:52 AM
|
|||
|
|||
JAK inhibitor provides rapid, durable relief for patients of myelofibrosis -- life-th
An oral medication produces significant and lasting relief for patients with myelofibrosis, a debilitating and lethal bone marrow disorder, researchers report.
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Rapid, Durable Relief For Myelofibrosis Patients Provided By JAK Inhibitor | cancerfr | Oral Cancer | 0 | 09-19-2010 04:01 AM |
| Novartis JAK Inhibitor Provides Marked And Durable Clinical Benefits In Patients With | cancerfr | Multiple Myeloma/Other Plasma Cell Neoplasms | 0 | 09-19-2010 04:01 AM |
| Novartis JAK inhibitor provides durable clinical benefits in blood cancer patients | cancerfr | Multiple Myeloma/Other Plasma Cell Neoplasms | 0 | 09-19-2010 04:01 AM |
| JAK oral medication produces lasting relief for patients with myelofibrosis: Research | cancerfr | Oral Cancer | 0 | 09-17-2010 01:48 AM |
| JAK inhibitor provides rapid, durable relief for myelofibrosis patients | cancerfr | Oral Cancer | 0 | 09-17-2010 01:48 AM |
Linear Mode
